Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin ReductionShuhei Suzuki, Masashi Okada|Cancers|2019Cited by 42